{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:03:26Z","timestamp":1750658606279,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003751","name":"Ministerio de Sanidad, Servicios Sociales e Igualdad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00223-019-00570-9","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T05:14:08Z","timestamp":1559798048000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost-Effectiveness of the Screening for the Primary Prevention of Fragility Hip Fracture in Spain Using FRAX\u00ae"],"prefix":"10.1007","volume":"105","author":[{"given":"Mario","family":"Martin-Sanchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1926-2740","authenticated-orcid":false,"given":"Merc\u00e8","family":"Comas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Posso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Louro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Teb\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Espallargues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"issue":"1\u20132","key":"570_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11657-013-0144-1","volume":"8","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, Borgstr\u00f6m F, Compston J, Dreinh\u00f6fer K, Nolte E, Jonsson L et al (2013) SCOPE: a scorecard for osteoporosis in Europe. Arch Osteoporos 8(1\u20132):144","journal-title":"Arch Osteoporos"},{"issue":"1","key":"570_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40277-014-0029-8","volume":"12","author":"Y Gonz\u00e1lez","year":"2015","unstructured":"Gonz\u00e1lez Y, Sicras A, Larra\u00ednzar R, Sorio F, Canals L, Liz\u00e1n L et al (2015) Estimaci\u00f3n de los costes sanitarios relacionados con las fracturas osteopor\u00f3ticas en pacientes posmenop\u00e1usicas en Espa\u00f1a. Pharmacoeconomics Spanish Res Artic 12(1):1\u20139","journal-title":"Pharmacoeconomics Spanish Res Artic"},{"key":"570_CR3","doi-asserted-by":"crossref","unstructured":"Sozen T, Ozisik L, Calik Basaran N (2017) An overview and management of osteoporosis. Eur J Rheumatol 4(1):46\u201356. \n                    http:\/\/www.eurjrheumatol.org\/sayilar\/209\/buyuk\/46-56.pdf","DOI":"10.5152\/eurjrheum.2016.048"},{"issue":"982","key":"570_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/pgmj.2007.057505","volume":"83","author":"GM Blake","year":"2007","unstructured":"Blake GM, Fogelman I (2007) The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J 83(982):509\u2013517","journal-title":"Postgrad Med J"},{"issue":"1","key":"570_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-013-2504-5","volume":"25","author":"S Nayak","year":"2014","unstructured":"Nayak S, Edwards DL, Saleh AA, Greenspan SL (2014) Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review. Osteoporos Int 25(1):23\u201349","journal-title":"Osteoporos Int"},{"issue":"5","key":"570_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","volume":"44","author":"JA Kanis","year":"2009","unstructured":"Kanis JA, Oden A, Johansson H, Borgstr\u00f6m F, Str\u00f6m O, McCloskey E (2009) FRAX\u00ae and its applications to clinical practice. Bone 44(5):734\u2013743","journal-title":"Bone"},{"issue":"1","key":"570_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bone.2011.11.006","volume":"50","author":"J Gonz\u00e1lez-Mac\u00edas","year":"2012","unstructured":"Gonz\u00e1lez-Mac\u00edas J, Marin F, Vila J, D\u00edez-P\u00e9rez A (2012) Probability of fractures predicted by FRAX\u00ae and observed incidence in the Spanish ECOSAP study cohort. Bone 50(1):373\u2013377","journal-title":"Bone"},{"key":"570_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1471-2474-13-204","volume":"13","author":"R Azagra","year":"2012","unstructured":"Azagra R, Roca G, Encabo G, Aguy\u00e9 A, Zwart M, G\u00fcell S et al (2012) FRAX\u00ae tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort. BMC Musculoskelet Disord 13:204","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"570_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jocd.2012.05.007","volume":"16","author":"CT Cordom\u00ed","year":"2013","unstructured":"Cordom\u00ed CT, del R\u00edo LM, Di Gregorio S, Casas L, Estrada MD, Kotzeva A et al (2013) Validation of the FRAX predictive model for major osteoporotic fracture in a historical cohort of Spanish women. J Clin Densitom 16(2):231\u2013237","journal-title":"J Clin Densitom"},{"key":"570_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","volume":"391","author":"L Shepstone","year":"2017","unstructured":"Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R et al (2017) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391:741\u2013747","journal-title":"Lancet"},{"issue":"1\u20132","key":"570_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Iverg\u00e5rd M, Compston J, Cooper C, Stenmark J et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1\u20132):136","journal-title":"Arch Osteoporos"},{"key":"570_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001155.pub2","author":"G Wells","year":"2011","unstructured":"Wells G, Cranney A, Peterson J, Boucher M, Shea B, Welch V et al (2011) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women (Review). Cochrane Libr. \n                    https:\/\/doi.org\/10.1002\/14651858.CD001155.pub2","journal-title":"Cochrane Libr"},{"issue":"1","key":"570_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00198-010-1274-6","volume":"22","author":"SL Silverman","year":"2011","unstructured":"Silverman SL, Schousboe JT, Gold DT (2011) Oral bisphosphonate compliance and persistence: a matter of choice? Osteoporos Int 22(1):21\u201326","journal-title":"Osteoporos Int"},{"issue":"3","key":"570_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1503\/cmaj.121874","volume":"186","author":"TLN J\u00e4rvinen","year":"2014","unstructured":"J\u00e4rvinen TLN, Jokihaara J, Guy P, Alonso-Coello P, Collins GS, Micha\u00eblsson K et al (2014) Conflicts at the heart of the FRAX tool. CMAJ 186(3):165\u2013167","journal-title":"CMAJ"},{"issue":"5","key":"570_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/jbmr.3381","volume":"33","author":"DA Turner","year":"2018","unstructured":"Turner DA, Khioe RFS, Shepstone L, Lenaghan E, Cooper C, Gittoes N et al (2018) The cost-effectiveness of screening in the community to reduce osteoporotic fractures in older women in the UK: economic evaluation of the SCOOP study. J Bone Miner Res 33(5):845\u2013851","journal-title":"J Bone Miner Res"},{"issue":"8","key":"570_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0135475","volume":"10","author":"G Sanf\u00e9lix-Gimeno","year":"2015","unstructured":"Sanf\u00e9lix-Gimeno G, Hurtado I, Sanf\u00e9lix-Genov\u00e9s J, Baixauli-P\u00e9rez C, Rodr\u00edguez-Bernal CL, Peir\u00f3 S (2015) Overuse and underuse of antiosteoporotic treatments according to highly influential osteoporosis guidelines: a population-based cross-sectional study in Spain. PLoS ONE 10(8):1\u201313","journal-title":"PLoS ONE"},{"issue":"6","key":"570_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.gaceta.2011.06.007","volume":"25","author":"C Teb\u00e9","year":"2011","unstructured":"Teb\u00e9 C, del R\u00edo LM, Casas L, Estrada MD, Kotzeva A, Di Gregorio S et al (2011) Factores de riesgo de fracturas por fragilidad en una cohorte de mujeres espa\u00f1olas. Gac Sanit 25(6):507\u2013512","journal-title":"Gac Sanit"},{"key":"570_CR18","unstructured":"Arribas D, Ben\u00edtez D, Carbonell C, Cebamanos J, del R\u00edo L (2010) Gu\u00eda de Pr\u00e1ctica Cl\u00ednica sobre Osteoporosis y Prevenci\u00f3n de Fracturas por Fragilidad. Gu\u00edas Pr\u00e1ctica Cl\u00ednica En El Sns. 1\u2013263. \n                    http:\/\/www.guiasalud.es\/GPC\/GPC_476_Osteoporosis_AIAQS_compl.pdf"},{"key":"570_CR19","unstructured":"Observatorio de Salud de Catalu\u00f1a. Central de Resultados. Observatorio del Sistema de Salud de Catalu\u00f1a; 2018. \n                    http:\/\/observatorisalut.gencat.cat"},{"key":"570_CR20","unstructured":"INEbase (2016) Madrid: Instituto Nacional de Estad\u00edstica. \n                    www.ine.es\/inebmenu\/indice.htm"},{"issue":"24","key":"570_CR21","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","volume":"280","author":"SR Cummings","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. J Am Med Assoc 280(24):2077\u20132082","journal-title":"J Am Med Assoc"},{"issue":"2","key":"570_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00198-011-1549-6","volume":"23","author":"E Landfeldt","year":"2012","unstructured":"Landfeldt E, Str\u00f6m O, Robbins S, Borgstr\u00f6m F (2012) Adherence to treatment of primary osteoporosis and its association to fractures-the Swedish adherence register analysis (SARA). Osteoporos Int 23(2):433\u2013443","journal-title":"Osteoporos Int"},{"issue":"4","key":"570_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1524-4733.2004.74002.x","volume":"7","author":"JL Severens","year":"2004","unstructured":"Severens JL, Milne RJ, Severens H (2004) Discounting health outcomes in economic evaluation: the ongoing debate. Value Health 7(4):397\u2013401","journal-title":"Value Health"},{"key":"570_CR24","unstructured":"Montserrat J, Rodr\u00edguez-Cabrero G (2002) Modelos de atenci\u00f3n sociosanitaria. Una aproximaci\u00f3n a los costes de la dependencia. IMSERSO. p 172. \n                    http:\/\/envejecimiento.csic.es\/documentos\/documentos\/montserrat-modelos-01.pdf"},{"key":"570_CR25","unstructured":"Ley 39\/2006, de 14 de diciembre, de Promoci\u00f3n de la Autonom\u00eda Personal y Atenci\u00f3n a las personas en situaci\u00f3n de dependencia de Espa\u00f1a"},{"key":"570_CR26","first-page":"9","volume":"2014","author":"J Puig-Junoy","year":"2014","unstructured":"Puig-Junoy J, Oliva-Moreno J, Trapero-Bertr\u00e1n M, Abell\u00e1n-Perpi\u00f1\u00e1n JM et al (2014) Gu\u00eda y recomendaciones para la realizaci\u00f3n y presentaci\u00f3n de evaluaciones econ\u00f3micas y an\u00e1lisis de impacto presupuestario de medicamentos en el \u00e1mbito del CatSalut. General Catalunya Dep Salut Serv Catal\u00e0 la Salut Barcelona 2014:9\u201311","journal-title":"General Catalunya Dep Salut Serv Catal\u00e0 la Salut Barcelona"},{"issue":"1","key":"570_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jbspin.2012.01.001","volume":"80","author":"K Alzahouri","year":"2013","unstructured":"Alzahouri K, Bahrami S, Durand-Zaleski I, Guillemin F, Roux C (2013) Cost-effectiveness of osteoporosis treatments in postmenopausal women using FRAXTM Thresholds for decision. Jt Bone Spine 80(1):64\u201369","journal-title":"Jt Bone Spine"},{"issue":"10","key":"570_CR28","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00198-011-1668-0","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Cooper C, Hiligsmann M, Rabenda V, Reginster JY, Rizzoli R (2011) Partial adherence: a new perspective on health economic assessment in osteoporosis. Osteoporos Int 22(10):2565\u20132573","journal-title":"Osteoporos Int"},{"issue":"1","key":"570_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bone.2004.08.018","volume":"36","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Borgstrom F, Zethraeus N, Johnell O, Oden A, J\u00f6nsson B (2005) Intervention thresholds for osteoporosis in the UK. Bone 36(1):22\u201332","journal-title":"Bone"},{"issue":"11","key":"570_CR30","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-207907","volume":"74","author":"A Marques","year":"2015","unstructured":"Marques A, Ferreira RJO, Santos E, Loza E, Carmona L, da Silva JAP (2015) The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1958\u20131967. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2015-207907","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"570_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/joim.12366","volume":"277","author":"TLN J\u00e4rvinen","year":"2015","unstructured":"J\u00e4rvinen TLN, Micha\u00eblsson K, Aspenberg P, Siev\u00e4nen H (2015) Osteoporosis: the emperor has no clothes. J Intern Med 277(6):662\u2013673","journal-title":"J Intern Med"},{"issue":"12","key":"570_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/1759720X17732562","volume":"9","author":"WF Lems","year":"2017","unstructured":"Lems WF, Raterman HG (2017) Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs. Ther Adv Musculoskelet Dis 9(12):299\u2013316","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"570_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00223-016-0132-8","volume":"99","author":"A Marques","year":"2016","unstructured":"Marques A, Louren\u00e7o \u00d3, Orts\u00e4ter G, Borgstr\u00f6m F, Kanis JA, da Silva JAP (2016) Cost-effectiveness of intervention thresholds for the treatment of osteoporosis based on FRAX\u00ae in Portugal. Calcif Tissue Int 99(2):131\u2013141","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"570_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.7326\/0003-4819-155-11-201112060-00007","volume":"155","author":"S Nayak","year":"2011","unstructured":"Nayak S, Roberts MS, Greenspan SL (2011) Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann Intern Med 155(11):751\u2013761","journal-title":"Ann Intern Med"},{"issue":"11","key":"570_CR35","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s00198-011-1869-6","volume":"23","author":"K Lippuner","year":"2012","unstructured":"Lippuner K, Johansson H, Borgstr\u00f6m F, Kanis JA, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX\u00ae in Switzerland. Osteoporos Int 23(11):2579\u20132589","journal-title":"Osteoporos Int"},{"issue":"6","key":"570_CR36","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00198-014-2698-1","volume":"25","author":"K Zarca","year":"2014","unstructured":"Zarca K, Durand-Zaleski I, Roux C, Souberbielle JC, Schott AM, Thomas T et al (2014) Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: A Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture. Osteoporos Int 25(6):1797\u20131806","journal-title":"Osteoporos Int"},{"issue":"2","key":"570_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jbmr.1758","volume":"28","author":"L Nshimyumukiza","year":"2013","unstructured":"Nshimyumukiza L, Durand A, Gagnon M, Douville X, Morin S, Lindsay C et al (2013) An economic evaluation: simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures. J Bone Miner Res 28(2):383\u2013394","journal-title":"J Bone Miner Res"},{"issue":"2","key":"570_CR38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00198-016-3782-5","volume":"28","author":"M Yoshimura","year":"2017","unstructured":"Yoshimura M, Moriwaki K, Noto S, Takiguchi T (2017) A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women. Osteoporos Int 28(2):643\u2013652. \n                    https:\/\/doi.org\/10.1007\/s00198-016-3782-5","journal-title":"Osteoporos Int"},{"key":"570_CR39","unstructured":"Madrid: Instituto Nacional de Estad\u00edstica. INEbase; 2015. \n                    www.ine.es\/inebmenu\/indice.htm"},{"issue":"3","key":"570_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.reumae.2012.04.009","volume":"8","author":"MJ Pueyo","year":"2012","unstructured":"Pueyo MJ, Larrosa M, Suris X, Garcia-Ruiz AJ (2012) Cost-utility and budget impact analysis of primary prevention with alendronate of osteoporotic hip fractures in Catalonia. Reumatol Clin 8(3):128\u2013134. \n                    https:\/\/doi.org\/10.1016\/j.reumae.2012.04.009","journal-title":"Reumatol Clin"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00570-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-019-00570-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00570-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:13:49Z","timestamp":1591312429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-019-00570-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1007\/s00223-019-00570-9","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"type":"print","value":"0171-967X"},{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"7 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"MM, MC, MP, JL, LD, CT, XC and ME declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Research based on secondary data, informed consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Research involving humans and\/or animals. This article does not contain any studies with human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}